NDC 51662-1330

DOBUTAMINE

Dobutamine

DOBUTAMINE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Dobutamine Hydrochloride.

• Product ID: 51662-1330_85fb5ba6-3598-e09f-e053-2a91aa0aded5
• NDC: 51662-1330
• Product Type: Human Prescription Drug
• Proprietary Name: DOBUTAMINE
• Generic Name: Dobutamine
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2019-04-07
• Marketing Category: NDA / NDA
• Application Number: NDA020201
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: DOBUTAMINE HYDROCHLORIDE
• Active Ingredient Strength: 200 mg/100mL
• Pharm Classes: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1330-1

250 mL in 1 BAG (51662-1330-1)

• Marketing Start Date: 2019-04-07
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1330-1 [51662133001]

DOBUTAMINE INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA020201
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-04-07

Drug Details

Active Ingredients

Ingredient	Strength
DOBUTAMINE HYDROCHLORIDE	200 mg/100mL

OpenFDA Data

• SPL SET ID: 85fb5ba6-3597-e09f-e053-2a91aa0aded5
• Manufacturer:
  • HF Acquisition Co LLC, DBA HealthFirst
• UNII:
  • 0WR771DJXV

Pharmacological Class

• Adrenergic beta-Agonists [MoA]
• beta-Adrenergic Agonist [EPC]

NDC Crossover Matching brand name "DOBUTAMINE" or generic name "Dobutamine"

NDC	Brand Name	Generic Name
0409-2025	DOBUTAMINE	DOBUTAMINE
0409-2344	DOBUTAMINE	DOBUTAMINE
14335-171	Dobutamine	Dobutamine
14335-172	Dobutamine	Dobutamine
51662-1330	DOBUTAMINE	DOBUTAMINE
51662-1337	DOBUTAMINE	DOBUTAMINE
52584-048	Dobutamine	Dobutamine Hydrochloride Injection